Background The management of perianal Crohn's fistulas represents a significant
challenge. A combination of medical and surgical therapy, guided by radiology, is often …

Background Fistulas occur in about 25% of patients with Crohn's disease (CD) and can be
difficult to treat. The aim of this consensus was to provide guidance for the management of …

Summary Background Treatment paradigms for Crohn′ s disease with perianal fistulae
(CD‐pAF) are evolving. Aims To study the impact of multimodality treatment in CD‐pAF on …

Abstract Background and Aims: Perianal fistulas affect up to one-third of Crohn's patients
during the course of their disease. Despite the considerable disease burden, current …

Introduction: Managing fistulizing perianal disease is among the most challenging aspects of
treating patients with Crohn's disease. Perianal fistulas are indicative of poor long-term …

Complex perianal fistulas have a negative impact on the quality of life of sufferers and
should be treated. Correct diagnosis, characterization and classification of the fistulas are …

Abstract Background and Aims Most patients with perianal Crohn's fistula receive medical
treatment with anti-tumour necrosis factor [TNF], but the results of anti-TNF treatment have …

Perianal symptoms are common in patients with Crohn's disease and cause considerable
morbidity. The etiology of these symptoms include skin tags, ulcers, fissures, abscesses …

Summary Background Guidelines on Crohn's perianal fistulas recommend anti-tumour
necrosis factor (TNF) treatment and suggest considering surgical closure for patients with …

Abstract Background Perianal fistulising Crohn's disease (PFCD) affects a third of Crohn's
disease patients and represents a disabling phenotype with poor outcome. The anti-tumour …